New proton beam device tested for safer cancer treatment
NCT ID NCT07152353
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial is testing a new proton beam therapy device called PROTEUS® PLUS for treating solid tumors in adults. 47 participants will receive radiation from this machine to see if it is safe and effective at controlling tumors. The goal is to gather data for product registration and potentially offer a more precise treatment option.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Proton beam therapy (PROTEUS® PLUS device)
What this could lead to
If successful, this could provide a safer, more precise radiation option for treating various solid tumors, potentially reducing side effects compared to standard radiation.
What could go wrong
This is an early-stage device trial with only 47 participants, so results may not apply to all patients. Proton therapy is not new, and this specific system may not prove safer or more effective than existing options. Side effects from radiation, including toxicity, are still possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sichuan Cancer Hospital & Institute
Chengdu, Sichuan, China